[Skip to Content]
[Skip to Content Landing]
Article
August 1960

Treatment of Pernicious Anemia with Orally Administered Cyanocobalamin (Vitamin B12)

Author Affiliations

Baltimore

From the Department of Medicine, The Johns Hopkins University and Hospital.

Arch Intern Med. 1960;106(2):280-292. doi:10.1001/archinte.1960.03820020120018
Abstract

Introduction  Parenteral injection of cyanocobalamin (Vitamin B12) is well established as an effective and reliable treatment for pernicious anemia. In contrast, currently available preparations for oral use have proved to be much less dependable.1 A study was initiated in 1950 in the hematology clinic of The Johns Hopkins Hospital to determine whether relatively large amounts of pure cyanocobalamin, when administered orally without intrinsic factor or other adjuvants, would provide adequate therapy for patients with pernicious anemia. The early results of this investigation2-4 as well as those obtained in other clinics 5-11 were favorable. This paper provides further observations on a group of patients receiving various doses of orally administered cyanocobalamin for periods of up to six and one-half years.

Materials and Methods  The diagnosis of pernicious anemia had been well established by clinical and hematological criteria in each patient chosen to participate in this study. In many

References
1.
Serum cyanocobalamin levels were determined in the laboratories of the Division of Clinical Pathology, Department of Medicine, at the University of Maryland School of Medicine through the courtesy of Dr. M. S. Sacks and Dr. C. Spurling.
2.
A normal concentration of cyanocobalamin in serum is not required for persisting and apparently complete hematological and clinical remission. Nevertheless, a regimen of therapy which provides normal serum levels gives complete assurance of adequacy of therapy. This assurance is particularly desirable when there are neurological manifestations.
3.
Bethell, F. H.; Castle, W. B.; Conley, C. L., and London, I. M.:  Present Status of Treatment of Pernicious Anemia ,  J.A.M.A. 171:2092, 1959.Crossref
4.
Conley, C. L.; Krevans, J. R.; Chow, B. F.; Barrow, C., and Lang, C. A.:  Observations on the Absorption, Utilization, and Excretion of Vitamin B12 ,  J. Lab. & Clin. Med. 38:84, 1951.
5.
Conley, C. L.; Green, T. W.; Hartmann, R. C., and Krevans, J. R.:  Prolonged Treatment of Pernicious Anemia with Vitamin B12 ,  Am. J. Med. 13:284, 1952.
6.
Conley, C. L., and Krevans, J. R.:  New Developments in the Diagnosis and Treatment of Pernicious Anemia ,  Ann. Int. Med. 43:758, 1955.
7.
Ungley, C. C.:  Absorption of Vitamin B12 in Pernicious Anaemia: I. Oral Administration Without Known Source of Intrinsic Factor ,  Brit. M.J. 2:905, 1950.
8.
Unglaub, W. G.; Rosenthal, H. L., and Goldsmith, G. A.:  Studies of Vitamin B12 in Serum and Urine Following Oral and Parenteral Administration ,  J. Lab. & Clin. Med. 43:143, 1954.
9.
Unglaub, W. G., and Goldsmith, G. A.:  Oral Vitamin B12 in the Treatment of Macrocytic Anemias ,  South. M.J. 48:261, 1955.
10.
Reisner, E. H., Jr.; Weiner, L.; Schittone, M. T., and Henck, E. A.:  Oral Treatment of Pernicious Anemia With Vitamin B12 Without Intrinsic Factor ,  New England J. Med. 253:502, 1955.
11.
Chalmers, J. N. M., and Hall, Z. M.:  Treatment of Pernicious Anemia With Oral Vitamin B12 Without Known Source of Intrinsic Factor ,  Brit. M.J. 1:1179, 1954.
12.
Chalmers, J. N. M., and Shinton, N. K.:  Absorption of Orally Administered Vitamin B12 in Pernicious Anaemia ,  Lancet 2:( (7060) )1298, 1958.
13.
Brody, E. A.; Estren, S., and Wasserman, L. R.:  Treatment of Pernicious Anemia by Oral Administration of Vitamin B12 Without Added Intrinsic Factor ,  New England J. Med. 260:361, 1959.
14.
Brecher, G., and Cronkite, E. P.:  Morphology and Enumeration of Human Blood Platelets ,  J. Appl. Physiol. 3:365, 1950.
15.
Cannan, R. K.:  Proposal for a Certified Standard for Use in Hemoglobinometry: Second and Final Report ,  Blood 13:1101, 1958.
16.
Hutner, S. H.; Michael, K. B., and Ross, G. I. M.:  A Sugar Containing Basal Medium for Vitamin B12 Assay with Euglena; Application to Body Fluids ,  J. Protozoology 3:101, 1956.
17.
Raccuglia, G., and Sacks, M. S.:  Vitamin B12 Binding Capacity of Normal and Leukemic Sera ,  J. Lab. & Clin. Med. 50:69, 1957.
18.
Schilling, R. F.:  Intrinsic Factor Studies: II. The Effect of Gastric Juice on the Urinary Excretion of Radioactivity After the Oral Administration of Radioactive Vitamin B12 ,  J. Lab. & Clin. Med. 42:860, 1953.
19.
Mollin, D. L., and Ross, G. I. M.:  Vitamin B12 Deficiency in the Megaloblastic Anaemias ,  Proc. Roy. Soc. Med. 47:428, 1954.
20.
Norregaard, S.:  Pernicios anaemi refraktaer overfor cytoplex ,  Ugesk. laeger 117:850, 1955.
21.
Mooney, F. S.:  Oral Treatment of Pernicious Anaemia ,  Practitioner 177:183, 1956.
22.
Lowenstein, L.; Brunton, L.; Shapiro, L.; DeLeeuw, N., and DuFresne, M.:  Maintenance Therapy of Pernicious Anaemia with Oral Administration of Intrinsic Factor and Vitamin B12 ,  Canad. M.A.J. 77:923, 1957.
23.
Adams, J. F.:  The Oral Maintenance Treatment of Pernicious Anaemia ,  Scottish M.J. 2:151, 1957.
24.
Schwartz, M.; Lous, P., and Meulengracht, E.:  Reduced Effect of Heterologous Intrinsic Factor After Prolonged Oral Treatment in Pernicious Anaemia ,  Lancet 272:751, 1957.Crossref
25.
Killander, A.:  Reduced Effect of Heterologous Intrinsic Factor ,  Lancet 272:1041, 1957.Crossref
26.
Kristensen, H. P. ø.; Lund, J.; Ohlsen, A. S., and Pedersen, J.:  Maintenance Therapy in Pernicious Anaemia Controlled by Determining Vitamin B12 Level in Plasma ,  Lancet 272:1266, 1957.Crossref
27.
Bastrup-Madsen, P.:  Oral Maintenance Therapy in Pernicious Anaemia with Vitamin B12 as Hog Intrinsic Factor ,  Acta med. scandinav. 159:323, 1957.Crossref
28.
Stokes, J. B., and Pitney, W. R.:  Pernicious Anaemia Treated Orally with B1 Factor: Refractoriness to Potent Animal Intrinsic Factor ,  Brit. M.J. 1:322, 1958.Crossref
29.
Berlin, R.; Berlin, H.; Brante, G., and Sjöberg, S. G.:  Failures in Long-Term Oral Treatment of Pernicious Anemia with B12-Intrinisc Factor Preparations ,  Acta med. scandinav. 161: 143, 1958.Crossref
30.
Doscherholmen, A., and Hagen, P. S.:  A Dual Mechanism of Vitamin B12 Plasma Absorption ,  J. Clin. Invest. 36:1551, 1957.Crossref
31.
Meacham, G. C., and Heinle, R. W.:  Maintenance Therapy of Pernicious Anemia with Vitamin B12 ,  J. Lab. & Clin. Med. 41:65, 1953.
32.
Beutler, E.:  The Red Cell Indices in the Diagnosis of Iron-Deficiency Anemia ,  Ann. Int. Med. 50:313, 1959.
33.
 Physicians' Desk Reference , Ed. 13, Oradell, N.J., Medical Economics, Inc., 1959, pp. 311-312.
34.
Conley, C. L., and Krevans, J. R.:  Development of Neurologic Manifestations of Pernicious Anemia During Multivitamin Therapy ,  New England J. Med. 245:529, 1951.
35.
Chow, B. F.; Meier, P., and Free, S. M., Jr.:  Absorption of Vitamin B12 Enhanced by D-Sorbitol ,  Am. J. Clin. Nutrition 6:30, 1958.
36.
Ellenbogen, L.; Herbert, V., and Williams, W. L.:  Effect of D-Sorbitol on Absorption of Vitamin B12 by Pernicious Anemia Patients ,  Proc. Soc. Exper. Biol. & Med. 99:257, 1958.
×